Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.

or nebulization (7%), or ipratropium bromide in a fixed-dose combination with albuterol (38%). Overall, exposure to anticholinergics was associated with a 29% higher risk of CVEs relative to no ...

SGRQ total score averaged over 24 wk: cilomilast improved ~3.6 points vs placebo worsened ~0.5 points (p < 0.001) pts. exacerbation-free at 24 wk: cilomilast 74% vs placebo 62% (p = 0.008 ...

Allergens are substances that cause an immune response ranging from a runny nose to shortness of breath. Allergic reactions ...

Bronchodilators to open the airways (e.g., albuterol or ipratropium bromide and albuterol) Untreated anaphylaxis can lead to hypotension (low blood pressure), incontinence, fainting, shock ...

MDIs can recognized by the abbreviation HFA (which stands for the propellant hydrofluoroalkane). These include Ventolin HFA, Proventil HFA, Proair HFA, Atrovent HFA, Alvesco HFA, and Asmanex HFA.

Formoterol can work as rapidly as five minutes, and its effects are maintained for up to 12 hours. Studies have also shown that formoterol controls symptoms better than ipratropium and is more ...

Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. The ...

Anaphylaxis is a life-threatening allergic reaction. It is a severe, whole-body reaction that requires immediate medical ...

A tapering course of prednisone and inhaled albuterol were prescribed ... furosemide and piperacillin–tazobactam and inhaled ipratropium were administered. Diagnostic tests were performed ...